FIELD: medicine.
SUBSTANCE: invention relates to creation of nutritional composition which includes colostrum and fat mixture for treatment of intestine dysfunction in HIV patients.
EFFECT: composition of colostrum and eicosapaentanoic (EPA) ensures synergetic effect with respect to protection against mediated by destructing action of cytokines in destruction of barrier layer in comparison with colostrum alone.
13 cl, 4 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| FEED SUPPLEMENT FOR AIDS PATIENTS (VERSIONS) | 2006 |
|
RU2421077C2 |
| METHOD FOR REDUCING THE OCCURENCE OF INFECTION IN INFANTS | 2012 |
|
RU2605198C2 |
| HIGH-CALORIC NUTRITIONAL COMPOSITIONS | 2008 |
|
RU2486772C2 |
| BALANCED FAT COMPOSITIONS AND THEIR APPLICATION IN LIQUID NUTRITIONAL COMPOSITIONS FOR ENTERAL FEEDING | 2010 |
|
RU2546865C2 |
| INTESTINAL BARRIER INTEGRITY IMPROVEMENT | 2004 |
|
RU2402240C2 |
| METHOD FOR NEUROTRAUMA TREATMENT | 2012 |
|
RU2622999C2 |
| NUTRITIVE COMPOSITION FOR MAMMAL IMMUNE SYSTEM IMPROVEMENT | 2009 |
|
RU2525429C2 |
| LIQUID ENTERAL NUTRIENT COMPOSITION SUITABLE FOR ENTERAL FEEDING, MINIMISING UPPER AND LOWER GASTROINTESTINAL COMPLICATIONS | 2010 |
|
RU2516782C2 |
| BETA-1,3'-GALACTOSYLLACTOSE FOR TREATING INTESTINAL BARRIER FUNCTION DISEASES | 2020 |
|
RU2818918C2 |
| METHOD FOR NEUROTRAUMA TREATMENT | 2012 |
|
RU2749191C2 |
